Amundi Asset Management US’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-31,716
Closed -$3.22M 1653
2019
Q4
$3.22M Sell
31,716
-174,478
-85% -$17.3M ﹤0.01% 1021
2019
Q3
$21.1M Buy
206,194
+5,102
+3% +$520K 0.03% 495
2019
Q2
$23.3M Buy
201,092
+34,349
+21% +$3.7M 0.02% 537
2019
Q1
$17.5M Buy
166,743
+42,323
+34% +$4.75M 0.02% 553
2018
Q4
$14M Buy
124,420
+26,800
+27% +$3.31M 0.01% 561
2018
Q3
$15.8M Buy
97,620
+48,800
+100% +$6.9M 0.02% 613
2018
Q2
$5.81M Sell
48,820
-10,000
-17% -$1.22M 0.01% 876
2018
Q1
$6.91M Buy
58,820
+24,000
+69% +$2.71M 0.01% 784
2017
Q4
$3.59M Buy
+34,820
New +$3.12M 0.01% 937

Other funds holding PRLB

Amundi Asset Management US's PRLB Position: Q1 2020 in Review

Amundi Asset Management US sold out of Protolabs (PRLB) in Q1 2020, closing a stake of 31,716 shares — an estimated $3.22M sold.

Amundi Asset Management US first reported a position in PRLB in Q4 2017 and held it in 9 quarters. The position peaked at $23.3M in Q2 2019. 234 funds tracked by Wall St. Rank hold PRLB as of Q1 2020.

  • Amundi Asset Management US reported no remaining Protolabs position as of Q1 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 31,716 Protolabs shares in Q1 2020, an estimated $3.22M.
  • Amundi Asset Management US first reported a position in Protolabs in Q4 2017 and held it in 9 quarters.
  • Amundi Asset Management US's Protolabs position peaked at $23.3M in Q2 2019.
  • 234 funds tracked by Wall St. Rank held Protolabs as of Q1 2020.

Based on Amundi Asset Management US's 13F filing for Q1 2020, filed 15 May 2020.